JMA’s Nakagawa Wants Clear Definitions for Original Drug, LLP, AG, Gx: Chuikyo

JMA Vice President Toshio Nakagawa Toshio Nakagawa, vice president of the Japan Medical Association (JMA) on June 28 prodded the health ministry to give clear definitions to “original drugs”, “long-listed products (LLPs)”, “authorized generics (AGs)”, and “generics” before a key...read more